GiveNOLA Day is a philanthropic day of giving to inspire people to give generously to nonprofits and make our Southeast Louisiana community thrive. AxoSim is committed to investing in the future of New Orleans and […]
Read MoreOn Wednesday, January 20th, 2021, at 11:10 am ET, AxoSim’s Chief Science Officer, Michael J. Moore, PhD, will be presenting at The National Academy of Science’s Workshop: Microphysiological Systems: Bridging Human and Animal Research. His […]
Read More2020 has been a rough year in so many ways – but this year, we’ve also seen many outstanding advances here at AxoSim and great progress in the microphysiological systems (MPS) field, in general. MPS […]
Read MoreOn Tuesday, December 8th, at 9am EST, AxoSim Consulting VP of Scientific Affairs, Thomas Hartung, MD, PhD, will be speaking on a Nature Research Custom Media Webcast: Translating Neurological Stem Cell Research into Therapies for […]
Read MoreBENSON CAPITAL PARTNERS ANNOUNCES FIRST INVESTMENT IN AXOSIM, INC. AxoSim, Inc, Provider of BrainSim™ and NerveSim™ Neurological Drug Discovery Platforms Teams with Benson Capital Partners and Jefferson Capital Partners For Immediate Release: November 5, 2020 […]
Read MoreOctober 30, 2020 –Two grants from the DoD Congressionally Directed Medical Research Program and the National Institutes of Health awarded to AxoSim– –The CDMRP grant will support the development of a ALS NerveSim™ model to […]
Read MoreAxoSim Scientist, Wesley Anderson, will be a Rapid Fire speaker at the 2020 AAPS PharmSci 360 Conference on Tuesday, November 3rd at 9:30am EST. His presentation is titled Development and Qualification of a Novel In […]
Read MoreOn Wednesday, September 30th, AxoSim Lead Scientist, Anup Sharma, PhD, spoke at our interactive webinar: Human Schwann Cells: Importance for Peripheral Neuropathy Preclinical Research. During this webinar, Dr. Sharma spoke about AxoSim’s Human Peripheral Co-Culture […]
Read MoreHigh Throughput, Human Data: AxoSim’s Human Peripheral Co-Culture Assay In addition to our 3D NerveSim™ and BrainSim™ models, AxoSim also performs a variety of cell-based 2D assays including our new Human Schwann Cell and iPSC-derived […]
Read MoreIntroducing our newest SimLab Service: Human Co-Culture Peripheral Assay We are excited to launch our newest assay which uses human Schwann cells and iPSC-derived neurons to recapitulate the results one can expect to see from […]
Read More